DAWN FARROW LTD
Company number 12478342 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
DAWN FARROW LTD - Analysis Report
Company Number: 12478342
Analysis Date: 2025-07-20 12:12 UTC
Financial Health Assessment for DAWN FARROW LTD
1. Financial Health Score: B
Explanation:
DAWN FARROW LTD exhibits solid financial health for a micro-entity with steady improvement in net assets and working capital over recent years. The company maintains a positive net current asset position and growing equity, indicative of a healthy balance sheet "heartbeat." However, the relatively small scale, limited fixed assets, and modest share capital temper the rating from an A to a B, highlighting room for growth and resilience enhancement.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 12,658 | Increased significantly from prior years, indicating investment in long-term resources—a positive sign of growth and capability building. |
| Current Assets | 51,643 | Healthy cash and receivables base that supports operational liquidity. |
| Current Liabilities | 30,653 | Manageable level of short-term obligations relative to current assets. |
| Net Current Assets | 21,337 | Strong positive working capital, indicating the company can comfortably cover short-term debts. |
| Net Assets (Equity) | 33,995 | Equity has more than doubled in two years, reflecting retained earnings and sound capital management. |
| Share Capital | 100 | Minimal share capital typical of micro-entities; majority funding likely from retained earnings. |
| Employees | 1 | Small team size consistent with micro company status; low fixed labor costs. |
3. Diagnosis
The financial "vital signs" for DAWN FARROW LTD show a company in good health with clear signs of financial strengthening. The substantial increase in fixed assets suggests strategic investment, potentially in equipment or technology, which may support future revenue growth. The strong net current assets indicate that the company has a "healthy cash flow" position, able to meet its short-term obligations without distress.
Equity growth from £10,683 in 2020 to £33,995 in 2024 shows robust accumulation of retained profits, signaling profitability or prudent financial management. The absence of overdue filings and the active status of the company further underscore operational stability.
However, as a micro-entity with limited scale, the company remains vulnerable to market fluctuations and external shocks. The sole director's control and small workforce imply dependencies that could impact resilience.
4. Recommendations
Maintain and Monitor Liquidity: Continue to monitor working capital ratios carefully to ensure the company can meet short-term obligations comfortably, especially if business scales up.
Leverage Fixed Asset Investments: Ensure the recent increase in fixed assets translates into higher productivity or revenue streams. Consider regular asset performance reviews.
Build Capital Buffer: Explore increasing share capital or external funding to strengthen the equity base, enhancing financial resilience.
Diversify Risk: Consider strategic planning to reduce dependencies on a single director and employee, perhaps by building a broader team or advisory network.
Financial Reporting and Forecasting: Implement forward-looking cash flow projections to anticipate any liquidity challenges, especially given the small size and potential market volatility.
Compliance Vigilance: Maintain timely filing of accounts and confirmation statements to avoid regulatory risk.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.